IL1B and cryopyrin-associated periodic syndrome: This activation occurs even in the absence of triggers or cell priming, and it influences the immunometabolism of CAPS patients, specifically by hindering glycolysis and consequently limiting IL-1β production and inflammatory flares, but orchestrating a specific inflammatory program against pathogens.